Canon's half-year results, filed with the Tokyo Stock Exchange on 27 July, show a company whose imaging business is doing the heavy lifting while its factory-equipment division loses ground.
Profit up, but unevenly
For the six months to 30 June 2026, Canon reported net sales of ¥2.27tn, up 3.5% from a year earlier, and operating profit of ¥230.6bn, up 7.6%. Net income attributable to Canon shareholders climbed 9.8% to ¥171.2bn, and basic earnings per share rose 16.8% to ¥197.51. Part of the gain came from an accounting change: Canon switched its depreciation method for fixed assets from the declining-balance method to straight-line from 1 January 2026, a shift the company says cut first-half depreciation expense by ¥12.6bn and added ¥8.7bn to net income, or ¥10.07 to basic earnings per share.
Imaging pulls its weight, industrial equipment falls behind
The four reporting segments moved in different directions. Imaging, which covers interchangeable-lens cameras, lenses, network cameras and cinema equipment, posted sales of ¥552.7bn, up 16.9%, and operating profit of ¥97.6bn, up 38.8%. Printing sales rose 1.5% to ¥1.24tn with operating profit up 5.0% to ¥157.5bn. Medical equipment sales slipped 0.7% to ¥277.4bn while operating profit fell 29.2% to ¥8.3bn, and the industrial unit, which makes semiconductor and flat-panel-display lithography equipment, saw sales fall 9.1% to ¥145.2bn and operating profit drop 33.1% to ¥17.4bn. The filing does not break out what drove the moves within each segment, so this release does not say whether cameras, lenses or a particular product line did the work inside imaging, or what weighed specifically on industrial and medical margins.
| Segment | Sales | Sales change | Operating profit | Profit change |
|---|---|---|---|---|
| Printing | ¥1,239.9bn | +1.5% | ¥157.5bn | +5.0% |
| Medical | ¥277.4bn | -0.7% | ¥8.3bn | -29.2% |
| Imaging | ¥552.7bn | +16.9% | ¥97.6bn | +38.8% |
| Industrial | ¥145.2bn | -9.1% | ¥17.4bn | -33.1% |
| Other and corporate | ¥112.9bn | -3.2% | -¥50.0bn (loss widened) | n/m |
Geographically, overseas sales rose 4.7% to ¥1.80tn, led by Europe (up 6.2% to ¥605.1bn) and the Americas (up 3.7% to ¥725.8bn), while domestic sales fell 1.1% to ¥475.6bn.
Outlook revised, dividend held
Canon revised its full-year forecast alongside the results, though the filing does not include the previously announced numbers for comparison. The company is now guiding for full-year net sales of ¥4.80tn, up 3.8% from the year to December 2025, operating profit of ¥465.0bn, up 2.1%, and net income attributable to shareholders of ¥340.0bn, up 2.4%. Canon confirmed an interim dividend of ¥80.00 per share and forecasts a full-year total of ¥160.00, unchanged from last year, targeting a payout ratio of around 40%. Shareholders' equity slipped 0.2% to ¥3.48tn even as total assets grew 4.0% to ¥6.38tn, pushing the equity ratio down to 54.6% from 56.9%.